Psychiatry · Katy, TX
NPI
1801848957
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
21613 Provincial Blvd
Katy, TX, 77450
Phone (713) 777-9900
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
794 services
Medicare patients, 2024
209
Average age 70
Drug cost, 2024
$1.5M
3,619 prescriptions
Company payments, 2025
$187K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Vikram Mehra was code 99213 (office e&m - established), 347 times for 109 patients. In total Vikram Mehra billed 794 services in 9 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 347 | 109 | $59.83 | $21K |
| 99231 Hospital E&M - Subsequent | Facility | 188 | 61 | $37.58 | $7,065 |
| 99232 Hospital E&M - Subsequent | Facility | 102 | 66 | $59.89 | $6,109 |
| 99223 Hospital E&M - Initial | Facility | 77 | 70 | $131.71 | $10K |
| 90792 Psychotherapy - Nongroup | Office | 34 | 34 | $138.07 | $4,694 |
| 99214 Office E&M - Established | Office | 28 | 27 | $94.18 | $2,637 |
| 99222 Hospital E&M - Initial | Facility | 16 | 16 | $97.94 | $1,567 |
By year: 2022 $23K for 365 services; 2023 $27K for 428 services; 2024 $53K for 794 services.
Medicare prescription drug claims, 2024
In 2024, the drug Vikram Mehra prescribed most often to Medicare patients was Diazepam, with 234 prescriptions and refills. In total Vikram Mehra wrote 3,619 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diazepam Generic | 234 | 247 | 93 | $1,693 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 215 | 237 | 43 | $8,418 |
| Trazodone Hcl Generic | 185 | 235 | 70 | $2,208 |
| Duloxetine Hcl Generic | 168 | 239 | 67 | $3,459 |
| Clonazepam Generic | 163 | 168 | 56 | $1,338 |
| Alprazolam Generic | 151 | 155 | 46 | $908 |
| Zolpidem Tartrate Generic | 145 | 161 | 57 | $934 |
| Lybalvi Olanzapine/Samidorphan Malate | 139 | 140 | 60 | $240K |
| Fluoxetine Hcl Generic | 108 | 130 | 31 | $933 |
| Gabapentin Generic | 105 | 115 | 45 | $1,309 |
| Quetiapine Fumarate Generic | 102 | 132 | 44 | $2,180 |
| Lorazepam Generic | 99 | 109 | 29 | $773 |
| Aristada Aripiprazole Lauroxil | 98 | 143 | 51 | $330K |
| Bupropion Xl Bupropion Hcl | 78 | 121 | 31 | $1,858 |
| Amitriptyline Hcl Generic | 74 | 76 | 25 | $1,480 |
Brand drugs: 525 claims; generic drugs: 3,094 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vikram Mehra $187K ($187K in general payments such as food, travel and fees) from 16 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $78K.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 154 | $78K |
| Alkermes, Inc. ALKS | 95 | $55K |
| Teva Pharmaceuticals USA, Inc. TEVA | 74 | $41K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 44 | $11K |
| Otsuka Pharmaceutical Development & Commercialization, Inc. 4578.T | 1 | $1,620 |
| Vanda Pharmaceuticals Inc. VNDA | 15 | $332 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 17 | $287 |
| Abbvie Inc. ABBV | 18 | $259 |
| Lundbeck LLC | 6 | $138 |
| Janssen Pharmaceuticals, Inc JNJ | 4 | $110 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.